Avidity Partners Management LP 13D and 13G filings for Zentalis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 7:43 pm Sale |
2023-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Avidity Partners Management LP | 0 0.000% |
-5,150,000 (Position Closed) |
Filing |
| 2023-02-14 12:02 pm Purchase |
2022-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Avidity Partners Management LP | 5,150,000 9.000% |
2,127,210 (+70.37%) |
Filing |
| 2022-02-01 3:33 pm Purchase |
2022-01-25 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Avidity Partners Management LP | 3,022,790 6.700% |
3,022,790 (New Position) |
Filing |